A Biologics License Application has been submitted to the FDA for treatment with the kidney cancer imaging PET drug product, Zircaix®.

Kidney cancer happens when cells in one or both kidneys start to grow out of control. Eventually, the cells become a mass called a tumor. As the cancer progresses, it can spread to other parts of the ...

The discovery could help explain why some cancer patients respond well to certain treatments, while others are not so lucky.

Fighting cancer can seem like a deadly game of chance. While some patients may respond well to certain treatments, others might not be as fortunate. Doctors and scientists have long struggled to ...

There are several types of kidney (renal) cancer. Each type is potentially curable if it’s found and treated early before the cancer has a chance to spread. Kidney cancer is categorized in stages from ...

Clayton's belly became very distended and his parents couldn't put a shirt on him. Tests showed the toddler had a Wilms tumor ...

Kombucha for a cause in honor of supporting childhood cancer research. Han’s Kombucha & HK brewing Collective are thrilled to ...

A biologics license application for TLX250-CDx has been submitted to the FDA, as supported by the phase 3 ZIRCON trial ...

MUSC Hollings Cancer Center researcher Aguirre de Cubas, Ph.D., is a recipient of the Department of Defense Academy of Kidney ...

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate (MTX), according to a new study. Using data from ...

Manmeet Ahluwalia, MD, MBA, FASCO, discusses the prevalence of brain metastases in patients with primary renal cell carcinoma.

When cells in your kidney grow out of control, kidney cancer can occur. Kidney cancer is rare and makes up about 2% of all cancers in the United States. Most people with kidney cancer don’t ...